1st Quarter - Report — ZIMMER BIOMET, INC. for ZIMMER BIOMET, INC. (2021)

Firm

ZIMMER BIOMET, INC.

Client

ZIMMER BIOMET, INC.

Income

—

Expenses

$150,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

COVID vaccine allocation and funding; Equitable access to medical technology

Lobbyist	Covered position, as disclosed
HEATHER FALEN ASHBY	—
ANDREW JAMES FRANKE	—

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC)

Trade (domestic/foreign) TRD

US-China Trade Issues

Lobbyist	Covered position, as disclosed
CHRISTOPHER A CERONE	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC)

Taxation/Internal Revenue Code TAX

Corporate Tax Legislation; Tax Cuts and Jobs Act changes; Internal Revenue Code Section 163j

Lobbyist	Covered position, as disclosed
CHRISTOPHER A CERONE	—
ANDREW JAMES FRANKE	—

Contacted: U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

FDA CFG Authentication Issue; Processing delay at US State Department

Lobbyist	Covered position, as disclosed
CHRISTOPHER A CERONE	—
HEATHER FALEN ASHBY	—

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.